Pretreating Recycled Carbon Fiber Nonwoven with a Sizing Formulation to Improve the Performance of Thermoplastic Recycled Fiber-Reinforced Composites.

Pyrolysis is already an established recycling method to recover the carbon fibers of end-of-life composites. However, the pyrolysis process removes the fiber sizing. Fiber sizing is a critical step in composite material production, influencing adhesion, protection and overall performance.

Approaches in Sustainable, Biobased Multilayer Packaging Solutions.

The depletion of fossil resources and the growing demand for plastic waste reduction has put industries and academic researchers under pressure to develop increasingly sustainable packaging solutions that are both functional and circularly designed. In this review, we provide an overview of the fundamentals and recent advances in biobased packaging materials, including new materials and techniques for their modification as well as their end-of-life scenarios. We also discuss the composition and modification of biobased films and multilayer structures, with particular attention to readily available drop-in solutions, as well as coating techniques.

Mentoring the Next Generation of Authors.

Objectives: To discuss the role of mentoring in writing for publication, describe the specific needs of millennial learners, and offer tips for both mentor and mentee on how to foster and maintain a positive mentorship.

Data Sources: Published literature, online sources, personal experience.

Conclusion: Mentorship can equip new nurse authors with the confidence, skills, and support needed to publish in a variety of forums.

Emerging immunology of stem cell transplantation.

Objectives: To review critical areas of recent advances in immunology related to hematopoietic stem cell transplantation (SCT) and developing science that hopefully will be translated into improvements in patient care.

Data Sources: Review of literature and electronic data.

Conclusion: An overwhelming amount of diverse information related to the science of immunology and hematopoietic SCT is available.

Dendritic cells: emerging roles in tumor immunotherapy.

The purpose of this article is to examine the use of myeloid dendritic cells (DCs) as immunotherapy in the treatment of cancer. DCs can be stimulated either from circulating blood or bone marrow progenitor cells using cytokines, particularly granulocyte macrophage-colony-stimulating factor (GM-CSF) (e.g.

Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy.

Healthcare providers believe they have a positive impact on controlling chemotherapy-induced nausea and vomiting (CINV), yet patients still consider CINV to be one of the most distressing side effects of chemotherapy. The effect of CINV on daily activities has been measured using the Functional Living Index-Emesis (FLIE) scale, a validated, nausea- and vomiting-specific, patient-reported outcome instrument comprising nine items in each of two domains. This research explores the potential correlation between reducing CINV and improved quality of life.

A dendritic cell primer for oncology nurses.

Once believed to be part of the nervous system, dendritic cells (DCs) now are known to be potent antigen-presenting cells of the immune system. Upon capturing a foreign antigen, the immature DC matures as it travels to the T cells to activate an immune response. DCs can be categorized into two main subsets: DC1s and DC2s.

Hematopoietic cell transplantation in the treatment of leukemia.

Objectives: To review the current evidence regarding the role and benefits of hematopoietic cell transplantation (HCT) in leukemia.

Data Sources: Review articles, original articles, internet web sites, and books.

Conclusion: HCT is a potentially curative treatment modality for patients with hematologic malignancies such as leukemia.

Nursing care of patients receiving Campath.

Monoclonal antibodies are focused therapies with unique infusion-related complications. Campath (alemtuzumab, Berlex Laboratories, Richmond, CA) is indicated for the treatment of refractory chronic lymphocytic leukemia and has a complicated administration schedule, severe infusion-related toxicity, and profound immunosuppressive capability. Ambulatory cancer care is challenging simply because of the complex nature of the disease.

Assessing patient satisfaction with pain management through a continuous quality improvement effort.

A quasi-experimental study was conducted to evaluate patient satisfaction with pain management before and after a continuous quality improvement (CQI) project in a large, university medical center. The CQI project aim was to implement American Pain Society (APS) quality improvement guidelines regarding the recognition and prompt treatment of pain. A modified version of the questionnaire recommended by the APS Subcommittee on Quality Assurance Standards was used to survey 83 patients prior to implementation of the CQI effort and 89 patients one year later.

Effect of subcutaneous granulocyte colony-stimulating factor injectate volume on drug efficacy, site complications, and client comfort.

Purpose/objectives: To determine the effect of administering 1.6 ml (480 mcg) of granulocyte colony-stimulating factor (G-CSF) in one subcutaneous injection or two injections of 0.8 ml each.

Management of dermatologic complications of chronic graft versus host disease: a case study.

The purpose of this article is to illustrate a multidisciplinary team collaborative approach to the management of dermatologic complications related to chronic graft versus host disease (GVHD). GVHD is a complication of allogeneic bone marrow transplantation (BMT) and peripheral blood cell transplantation (BCT). The skin is affected in more than 80% of patients with chronic GVHD who received a BMT.

Information guide for patients receiving total body irradiation before bone marrow transplantation.

Most patients with hematologic malignancies are conditioned for bone marrow transplantation with a regimen that includes the use of total body irradiation. This patient information guide was put together to simplify and standardize the type of instructions that patients receive before total body irradiation and to provide information for nurses who care for patients receiving such treatment. Content includes common questions asked by patients and families; a description of possible side effects; when side effects begin; and the patient's role in minimizing side effects.